FundingWatcher
Home / Funding rounds / Series B funding rounds / Series B startups in Massachusetts, United States

Series B startups in Massachusetts, United States

Updated 16 Nov 2026

Reset
Series B startups in Massachusetts, United States
One-time CSV
  • 472 funded companies, 395 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-round-series-b~massachusetts-united-states.csv472 rows × 18 columns
CompanyCityLast roundAmountDate
UltraSightCambridgeSeries B$24.0M2026-09-23
Superluminal MedicinesBostonSeries B$65.5M2026-09-03
SimnovaCambridgeSeries B$59.3M2026-08-18
Ozlo SleepNorthboroughSeries B$12.0M2026-06-04
Elemental MachinesCambridgeSeries B$5.7M2026-05-27
RemotePassBostonSeries B$17.4M2026-05-20
JuliaHubCambridgeSeries B$65.0M2026-04-30
KytopenCambridgeSeries B$1.6M2026-04-07

8 rows of the CSV in 5 of its 18 columns.

472
Startups
$28.7B
Total raised
37
Funded in the last 12 months
$2.5B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 472
30 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
UltraSight UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. Health care Cambridge Series B $24.0M 2026-09-23 $39.0M Yozma Group 11 to 50 2018
Superluminal Medicines Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. Artificial intelligence Boston Series B $65.5M 2026-09-03 $223.5M Insight Partners, RA Capital Management, NVentures 11 to 50 2022
Simnova Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. Biotech Cambridge Series B $59.3M 2026-08-18 $87.2M Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 51 to 100 2019
Ozlo Sleep Ozlo Sleep makes audio technology that helps people fall asleep without medication. Hardware Northborough Series B $12.0M 2026-06-04 $22.0M MedTech Innovator, Artis Ventures, LifeArc Ventures 11 to 50 2022
Elemental Machines Elemental Machines provides data-driven insights to improve research, laboratory operations, and manufacturing outcomes. Artificial intelligence Cambridge Series B $5.7M 2026-05-27 $66.5M Founders Fund, Tau Ventures, Rock Health Capital +2 11 to 50 2015
RemotePass RemotePass provides a platform for onboarding, managing, and paying contractors and employees. Fintech Boston Series B $17.4M 2026-05-20 $27.9M F6 Ventures, 212, BECO Capital +2 1,001 to 5,000 2021
JuliaHub JuliaHub provides a single platform for modeling, simulation, and building custom applications. Software Cambridge Series B $65.0M 2026-04-30 $107.8M General Catalyst, National Science Foundation, Menlo Ventures +2 101 to 250 2015
Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Cambridge Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017
Beacon Biosignals Beacon Biosignals uses neurotechnology to measure brain activity for clinical trials and patient treatment. Artificial intelligence Boston Series B $11.0M 2026-04-06 $127.0M General Catalyst, Half Court Ventures, Indicator Ventures +1 101 to 250 2019
Clasp.com Clasp.com is a fintech company helping employers attract and retain talent in hard-to-hire fields. Education Boston Series B $20.0M 2026-03-26 $180.8M Slow Ventures, Pear VC, Crosslink Capital +2 51 to 100 2018
Cloaked Cloaked provides digital identity and data protection tools for individuals and businesses focused on privacy. Cybersecurity Lowell Series B $375.0M 2026-03-19 $404.0M General Catalyst, Index Ventures, Lux Capital +1 101 to 250 2020
Allure Security Technology Allure Security Technology uses artificial intelligence to build anti-phishing defenses for enterprise customers. Artificial intelligence Waltham Series B $17.0M 2026-03-19 $55.0M Greycroft, Zetta Venture Partners, Glasswing Ventures +2 11 to 50 2009
Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Cambridge Series B $40.0M 2026-03-05 $260.0M Lux Capital, The Column Group, Nextech Invest 11 to 50 2021
Code Metal Code Metal provides AI-enabled, verifiable code translation and optimization for edge development and modernization. Artificial intelligence Boston Series B $125.0M 2026-02-19 $184.4M J2 Ventures, Shield Capital, Underdog Labs 51 to 100 2023
Precede Biosciences Precede Biosciences develops blood-based tests that reveal disease-defining transcriptional biology. Biotech Boston Series B $63.5M 2026-01-12 $140.5M Bristol-Myers Squibb, Lilly Asia Ventures, 5AM Ventures +2 11 to 50 2005
Diagonal Therapeutics Diagonal Therapeutics develops targeted therapies for cancer and genetic diseases. Biotech Watertown Series B $125.0M 2026-01-08 $253.0M Lightspeed Venture Partners, RA Capital Management, Atlas Venture +1 11 to 50 2022
Nocion Therapeutics Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. Biotech Cambridge Series B $23.0M 2026-01-07 $134.0M Canaan Partners, F-Prime, OUP (Osage University Partners) +2 11 to 50 2017
Myrtelle Myrtelle is a gene therapy company that runs clinical trials for rare monogenetic disorders. Biotech Wakefield Series B $30.5M 2025-12-23 $57.6M Panacea Venture 11 to 50 2020
Manifold Manifold provides machine learning tools that analyze operational data to support industrial and energy decisions. Artificial intelligence Newton Series B $18.0M 2025-12-18 $40.5M TQ Ventures, Calibrate Ventures, SK Ventures +1 101 to 250 2016
Sanegene Bio Sanegene Bio develops an RNAi drug discovery platform aimed at unmet clinical needs. Biotech Woburn Series B $110.0M 2025-12-08 $240.0M Shenzhen Capital Group, Qiming Venture Partners, Northern Light Venture Capital +1 51 to 100 2021
knownwell Knownwell offers a plug-and-play platform that consolidates data from multiple sources. Artificial intelligence Needham Series B $26.1M 2025-10-20 $50.6M Andreessen Horowitz, Flybridge, Flare Capital Partners +1 101 to 250 2022
MatrixSpace MatrixSpace builds AI-powered sensor and radar systems with software for real-time situational awareness. Artificial intelligence Burlington Series B $20.0M 2025-10-15 $60.1M Intel Capital, Raptor Group 101 to 250 2019
Kailera Therapeutics Kailera Therapeutics develops injectable and oral therapies for chronic weight management. Biotech Waltham Series B $600.0M 2025-10-14 $1.0B Atlas Venture, Bain Capital Life Sciences, RTW Investments 101 to 250 2024
Maven AGI Maven AGI offers a generative AI platform that reimagines customer experience, starting with support. Artificial intelligence Boston Series B $50.0M 2025-06-18 $78.0M Lux Capital, M13, E14 Fund 51 to 100 2023
Epicore Biosystems Epicore Biosystems develops sweat-sensing wearables that deliver personalized health insights. Hardware Cambridge Series B $6.0M 2025-05-01 $41.9M Alumni Ventures, National Institutes of Health, Joyance Partners +1 11 to 50 2017
AIRNA AIRNA develops RNA editing technologies to create medicines for various diseases. Biotech Cambridge Series B $155.0M 2025-04-01 $245.0M ARCH Venture Partners, Alexandria Venture Investments, Forbion Capital Partners +2 51 to 100 2021
VIA VIA helps energy companies use AI and blockchain to get value from their data. Artificial intelligence Somerville Series B $28.0M 2025-03-18 $47.2M Elemental Impact, The Westly Group, Massachusetts Clean Energy Center +2 11 to 50 2016
Stellaromics Stellaromics develops 3D in situ multi-omic analysis technology for biotechnology research. Biotech Natick Series B $80.0M 2025-02-11 $105.0M Plaisance Capital Management 11 to 50 2022
VideaHealth VideaHealth offers dentistAI software that automatically detects pathologies in dental imaging to help dentists avoid missed diagnoses. Biotech Boston Series B $40.0M 2025-01-28 $66.5M Spark Capital, Zetta Venture Partners, Pillar VC +2 51 to 100 2018
Pickle Robot Pickle Robot supplies AI-enabled robotic systems that unload trailers and containers. Artificial intelligence Cambridge Series B $50.0M 2024-11-11 $102.5M BoxGroup, DCVC, Toyota Ventures +2 101 to 250 2018

Table 1. Series B startups in Massachusetts, United States: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 472.

Series B startups in Massachusetts, United States by month2024-1122024-1212025-0142025-0232025-0322025-0432025-0522025-0612025-0722025-0822025-0922025-1052025-1122025-1242026-0172026-0212026-0362026-0432026-0532026-0652026-0812026-0922026-1022026-112
Figure 1. Series B startups in Massachusetts, United States by month of the round. Source: FundingWatcher. Data as of 16 November 2026. Base: 472.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Cloaked Cloaked provides digital identity and data protection tools for individuals and businesses focused on privacy. Cybersecurity Lowell Series B $375.0M 2026-03-19 $404.0M General Catalyst, Index Ventures, Lux Capital +1 101 to 250 2020
2 Code Metal Code Metal provides AI-enabled, verifiable code translation and optimization for edge development and modernization. Artificial intelligence Boston Series B $125.0M 2026-02-19 $184.4M J2 Ventures, Shield Capital, Underdog Labs 51 to 100 2023
3 Diagonal Therapeutics Diagonal Therapeutics develops targeted therapies for cancer and genetic diseases. Biotech Watertown Series B $125.0M 2026-01-08 $253.0M Lightspeed Venture Partners, RA Capital Management, Atlas Venture +1 11 to 50 2022
4 Sanegene Bio Sanegene Bio develops an RNAi drug discovery platform aimed at unmet clinical needs. Biotech Woburn Series B $110.0M 2025-12-08 $240.0M Shenzhen Capital Group, Qiming Venture Partners, Northern Light Venture Capital +1 51 to 100 2021
5 Superluminal Medicines Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. Artificial intelligence Boston Series B $65.5M 2026-09-03 $223.5M Insight Partners, RA Capital Management, NVentures 11 to 50 2022
6 JuliaHub JuliaHub provides a single platform for modeling, simulation, and building custom applications. Software Cambridge Series B $65.0M 2026-04-30 $107.8M General Catalyst, National Science Foundation, Menlo Ventures +2 101 to 250 2015
7 Precede Biosciences Precede Biosciences develops blood-based tests that reveal disease-defining transcriptional biology. Biotech Boston Series B $63.5M 2026-01-12 $140.5M Bristol-Myers Squibb, Lilly Asia Ventures, 5AM Ventures +2 11 to 50 2005
8 Simnova Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. Biotech Cambridge Series B $59.3M 2026-08-18 $87.2M Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 51 to 100 2019
9 Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Cambridge Series B $40.0M 2026-03-05 $260.0M Lux Capital, The Column Group, Nextech Invest 11 to 50 2021
10 Myrtelle Myrtelle is a gene therapy company that runs clinical trials for rare monogenetic disorders. Biotech Wakefield Series B $30.5M 2025-12-23 $57.6M Panacea Venture 11 to 50 2020

Table 2. Series B startups in Massachusetts, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 General Catalyst Venture capital firm San Francisco, United States 9 2% 3 JuliaHub, Beacon Biosignals, Cloaked
2 Alumni Ventures Angel group Manchester, United States 8 2%
3 Matrix Venture capital firm Cambridge, United States 8 2%
4 Atlas Venture Venture capital firm Cambridge, United States 7 1% 1 Diagonal Therapeutics
5 New Enterprise Associates Venture capital firm Menlo Park, United States 6 1%
6 .406 Ventures Venture capital firm Boston, United States 6 1%
7 Bain Capital Ventures Venture capital firm San Francisco, United States 6 1%
8 Highland Capital Partners Venture capital firm Lexington, United States 6 1%
9 Insight Partners Private equity firm New York, United States 5 1% 1 Superluminal Medicines
10 RA Capital Management Startup incubator Boston, United States 5 1% 2 Superluminal Medicines, Diagonal Therapeutics
11 National Science Foundation Entrepreneurship program Alexandria, United States 5 1% 2 JuliaHub, Kytopen
12 MassVentures Venture capital firm Boston, United States 5 1% 1 Kytopen
13 Lux Capital Venture capital firm New York, United States 5 1% 2 Cloaked, Atavistik Bio
14 F-Prime Venture capital firm Cambridge, United States 5 1% 1 Nocion Therapeutics
15 Intel Capital Corporate venture arm Santa Clara, United States 5 1%

Table 3. Series B startups in Massachusetts, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 211 45% $19.4B
Software 182 39% $7.9B
Biotech 168 36% $17.5B
Hardware 88 19% $3.1B
Artificial intelligence 47 10% $3.2B
Cybersecurity 34 7% $1.4B
Fintech 27 6% $897.8M
Commerce 25 5% $716.5M
Energy 9 2% $287.5M
Education 8 2% $317.0M

Table 4. Series B startups in Massachusetts, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 472 100% $18.0M

Table 5. Series B startups in Massachusetts, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Boston 147 31%
Cambridge 106 22%
Waltham 28 6%
Burlington 24 5%
Woburn 14 3%
Watertown 12 3%
Lexington 12 3%
Framingham 10 2%
Newton 9 2%
Needham 7 1%
Lowell 6 1%
Concord 6 1%

Table 6. Series B startups in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 2 5% $116.9M
October 2026 2 5% $285.0M
September 2026 2 5% $89.5M
August 2026 1 3% $59.3M
June 2026 5 14% $220.8M
May 2026 3 8% $145.1M
April 2026 3 8% $77.6M
March 2026 6 16% $539.0M
February 2026 1 3% $125.0M
January 2026 7 19% $488.5M
December 2025 4 11% $278.5M
November 2025 1 3% $59.2M

Table 7. Series B startups in Massachusetts, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 32 7% $2.1B
2025 32 7% $2.6B
2024 25 5% $1.2B
2023 34 7% $2.1B
2022 36 8% $2.2B
2021 44 9% $2.5B

Table 8. Series B startups in Massachusetts, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 6 1%
2020 to 2022 51 11%
2015 to 2019 128 27%
2010 to 2014 81 17%
Before 2010 203 43%

Table 9. Series B startups in Massachusetts, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 64 14%
11 to 50 191 42%
51 to 100 101 22%
101 to 250 56 12%
251 to 500 13 3%
501 to 1,000 11 2%
1,001 to 5,000 8 2%
5,001 to 10,000 4 1%
10,001 or more 4 1%

Table 10. Series B startups in Massachusetts, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many series b startups in Massachusetts, United States are on the list?
472, in the file dated 16 November 2026. 37 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 472 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Series B startups in Massachusetts, United States: 472 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Series B startups in Massachusetts by sector

Other funding stages in Massachusetts

Series B startups elsewhere

Cite: FundingWatcher, 472 companies in Massachusetts, United States whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/rounds/series-b/massachusetts-united-states/